Page 114 - Read Online
P. 114

Page 18 of 18                                           Franco et al. Hepatoma Res 2018;4:74  I  http://dx.doi.org/10.20517/2394-5079.2018.94


               198. Martin NK, Vickerman P, Dore GJ, Grebely J, Miners A, et al. Prioritization of HCV treatment in the direct-acting antiviral era: an
                   economic evaluation. J Hepatol 2016;65:17-25.
               199. Hickman M, Martin NK, Huxtable R. Hepatitis C virus prevention and treatment prioritization - ethical, economic and evidential
                   dimensions of early rather than delayed treatment for people who inject drugs. Addiction 2017;112:201-3.
               200. Lazarus JV, Stumo SR, Harris M, Hendrickx G, Hetherington KL, et al. Hep-CORE: a cross-sectional study of the viral hepatitis
                   policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc 2018;21:e25052.
               201. Box GEP. Science and statistics. J Am Stat Assoc 1976;71:791-9.
               202. Wiktor SZ. Where next for hepatitis B and C surveillance? J Viral Hepat 2015;22:571-3.
               203. Sixty-seventh World Health Assembly. Hepatitis. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf.
                   [Last accessed on 28 Nov 2018]
               204. Lazarus JV, Mozalevskis A, Safreed-Harmon K, Eramova I. Strengthening hepatitis B and C surveillance in Europe: results from the
                   two global hepatitis policy surveys (2013 and 2014). Hepatol Med Policy 2016;1:3.
               205. WHO. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Available from: www.
                   measlesrubellainitiative.org/wp-content/uploads/2013/06/WHO-surveillance-standard.pdf. [Last accessed on 28 Nov 2018]
               206. Irving WL, Brown RJ. Acute hepatitis C virus infection: a dynamic-and challenging-concept. J Infect Dis 2010;202:1765-7.
               207. Klevens RM, Miller J, Vonderwahl C, Speers S, Alelis K, et al. Population-based surveillance for hepatitis C virus, United States,
                   2006-2007. Emerg Infect Dis 2009;15:1499-502.
               208. The National Academies Press. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C (2010).
                   Available from: http://www.nap.edu/catalog/12793.html. [Last accessed on 28 Nov 2018]
   109   110   111   112   113   114   115   116   117   118   119